Demonstrates Sustained

Related by string. * demon strate . DEMONSTRATES . DEMONSTRATE . demonstrates . demonstrate : demonstrate Masimo SET . Demonstrates Efficacy . amply demonstrates . amply demonstrate . Demonstrates Potential / sustains . Sustaining . sustaining . sustained . Sustainer : Maximum sustained winds . Maximum Sustained Winds . sustained mild concussion . Sustained Excellence Award * *

Related by context. Frequent words. (Click for all words.) 77 Meets Primary Endpoint 75 Improves Survival 75 Completes Enrollment 74 Receives Orphan Drug Designation 74 Drug Shows Promise 74 Single Dose 73 Patient Enrollment 73 Reduces Risk 73 Presents Positive 73 Elderly Patients 73 FDA Accepts 73 Osteoporosis Drug 73 Phase III Clinical Trial 73 Study Demonstrates 73 Clinical Trial Results 73 Significantly Improves 73 Initiates Phase II 72 Significantly Improved 72 Pediatric Patients 72 Meta Analysis 72 Gastric Cancer 72 Advanced Prostate Cancer 72 Phase III Trial 72 Pivotal Phase 72 Renal Cell Carcinoma 72 Significantly Reduces 72 Atopic Dermatitis 71 Drug Candidate 71 Hepatocellular Carcinoma 71 Pivotal Phase III 71 Venous Thromboembolism 71 FDA Clears 71 Heart Failure Patients 71 Chronic Hepatitis C 70 Patients Undergoing 70 Overactive Bladder 70 Prostate Cancer Patients 70 Preclinical Data 70 Metastatic Melanoma 70 Develop Novel 70 #-# Full Text 69 Autoimmune Diseases 69 Pivotal Trial 69 RNAi Therapeutics 69 J Am Acad 69 Drug Resistant 69 Cholesterol Drug 69 J Am Coll 69 Increases Risk 69 Postmenopausal Women 69 Pulmonary Arterial Hypertension 69 Arthritis Drug 69 II Clinical Trial 69 Chronic Heart Failure 68 Myelodysplastic Syndromes 68 Eculizumab 68 Significantly Reduced 68 Patients Treated 68 Obese Patients 68 Systematic Review 68 Small Molecule 68 Chronic Hepatitis B 68 Pivotal Study 68 Urinary Incontinence 68 Commences Phase 68 Announces FDA Clearance 68 Smallpox Vaccine 68 Autoimmune Disease 68 Clinical Outcomes 68 Benign Prostatic Hyperplasia 68 Blood Thinner 68 Inflammatory Diseases 68 Breast Cancer Treatment 68 Generic Version 68 Patient Outcomes 68 Initiate Phase 67 Cognitive Impairment 67 Acute Coronary Syndromes 67 Cardiometabolic 67 Post Operative 67 Low Dose 67 Randomized Controlled Trial 67 Acute Ischemic Stroke 67 Golimumab 67 Arch Neurol 67 Inhaled Insulin 67 Ischemic 67 Myelofibrosis 67 Gender Differences 67 Well Tolerated 67 J Clin 67 Surgical Treatment 67 Glycemic Control 67 Metastatic Colorectal Cancer 67 Monotherapy 66 Prostate Cancer Treatment 66 Recombinant Human 66 Lung Cancer Patients 66 Newly Diagnosed 66 Aliskiren 66 Urinary Tract Infections

Back to home page